C
Edwards Lifesciences Corporation EW
$81.05 -$0.78-0.95% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 4.15B 4.18B 4.17B 4.16B 1.47B
Total Depreciation and Amortization 151.80M 153.30M 155.20M 149.30M 151.70M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -3.43B -3.53B -3.53B -3.49B -50.50M
Change in Net Operating Assets -71.90M 73.40M -259.30M -12.30M -708.10M
Cash from Operations 794.90M 876.20M 542.30M 806.40M 866.10M
Capital Expenditure -207.00M -243.10M -252.40M -290.90M -294.30M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -1.06B -1.06B -1.06B -717.60M 46.00M
Divestitures 3.93B 3.93B 3.93B 3.93B --
Other Investing Activities -620.40M -287.40M -300.30M -15.20M 539.30M
Cash from Investing 2.04B 2.34B 2.31B 2.90B 291.00M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 214.70M 167.30M 179.50M 184.10M 183.60M
Repurchase of Common Stock -1.31B -1.47B -1.16B -1.61B -781.10M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -58.40M -2.20M -3.10M -1.20M 6.10M
Cash from Financing -1.15B -1.30B -983.00M -1.42B -591.40M
Foreign Exchange rate Adjustments -47.80M 11.20M 38.60M -15.80M 44.90M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1.63B 1.92B 1.91B 2.27B 610.60M